Publication: 266

MicroRNA expression in cytogenetically normal acute myeloid leukemia.
      Google Scholar   
Citation:
N Engl J Med vol 358 (18) 1919-28
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
605  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA16058, CA102031, CA101140, U10 CA077658, CA41287, U10 CA035279, CA03927, CA35279, U10 CA101140, P30 CA016058, CA77658, CA114725, CA31946, U10 CA003927  
Corr. Author:
 
Authors:
                                       
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-19808, CALGB-20502, CALGB-8461, CALGB-9621, CALGB-9665
Phases:
1, 3, N/A
Keywords:
Adult, Analysis of Variance, DNA-Binding Proteins, Female, Gene Expression, Gene Expression Profiling, Gene Expression Regulation, Leukemic, Genetic Markers, Genetic Predisposition to Disease, Humans, Kaplan-Meier Estimate, Leukemia, Myeloid, Acute, MicroRNAs, Middle Aged, Mutation, Nuclear Proteins, Oligonucleotide Array Sequence Analysis, Prognosis, Proportional Hazards Models, RNA Probes, RNA, Neoplasm, Trans-Activators, Transcriptional Regulator ERG, fms-Like Tyrosine Kinase 3